Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances.

about

Machine learning applications for prediction of relapse in childhood acute lymphoblastic leukemia.Effects of CB2 and TRPV1 receptors' stimulation in pediatric acute T-lymphoblastic leukemia.

P2860

Q38636061-ACF52846-E9EC-4EB6-BA18-23C9508A8FC1 Q55216431-11BDEB45-EFD2-4D80-AFBA-F36AEF4B9FED

P2860

Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances.

Item

http://www.wikidata.org/entity/Q38922016

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Treatment of Childhood Acute L ...... Factors and Clinical Advances.

@en

type

Item

label

Treatment of Childhood Acute L ...... Factors and Clinical Advances.

@en

prefLabel

Treatment of Childhood Acute L ...... Factors and Clinical Advances.

@en

P1476

Treatment of Childhood Acute L ...... Factors and Clinical Advances.

@en

P2093

Lewis B Silverman

http://www.w3.org/2001/XMLSchema#string

Lynda M Vrooman

http://www.w3.org/2001/XMLSchema#string

P2860

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

Treating childhood acute lymphoblastic leukemia without cranial irradiation

Cancer statistics, 2016

Chimeric antigen receptor T cells for sustained remissions in leukemia

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.

P2888

s11899-016-0337-y

P304

385-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11899-016-0337-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1016712037

http://www.w3.org/2001/XMLSchema#string

P698

27502091

http://www.w3.org/2001/XMLSchema#string

Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances.

about

P2860

P2860

Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698